protein

Recombinant Cynomolgus Monkey CTLA-4 Fc Chimera Protein, CF

9336-CT-200

200 ug (also 1 mg)

480 USD

9336-CT-200

Recombinant Cynomolgus Monkey CTLA-4 Fc Chimera Protein, CF

200 ug (also 1 mg)

The Recombinant Cynomolgus Monkey CTLA-4 Fc Chimera Protein, CF from R&D Systems is derived from HEK293. The Recombinant Cynomolgus Monkey CTLA-4 Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.

CTLA-4

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS.

Unconjugated

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.

Cynomolgus Monkey

46-57 kDa, reducing conditions

40 kDa

Measured by its binding ability in a functional ELISA. When Recombinant Cynomolgus Monkey CTLA-4 Fc Chimera is coated at 0.5 ╡g/mL, 100 ╡L/well, Recombinant Human B7-1/CD80 Fc Chimera (Catalog # 140-B1 ) binds with an ED50 of 5-30 ng/mL.

<0.10 EU per 1 ╡g of the protein by the LAL method.

Recombinant Cynomolgus Monkey CTLA-4 Fc Chimera Protein Bioactivity

XP_005574071

Bioactivity

Human embryonic kidney cell, HEK293-derived cynomolgus monkey CTLA-4 protein Cynomolgus Monkey CTLA-4 (Ala37-Asp161) Accession # XP_005574071 IEGRMD Human IgG1 (Pro100-Lys330) N-terminus C-terminus

HEK293

480 USD

CD, CD152, CD152 antigen, CD152IDDM12, CD28, celiac disease 3, CELIAC3, CTLA4, CTLA-4, cytotoxic T-lymphocyte antigen 4, cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, cytotoxic T-lymphocyte-associated protein 4, cytotoxic T-lymphocyte-associated serine esterase-4, GRD4, GSE, ICOS, ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.